# Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3

> **NCT00685945** · NA · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 24 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Control (bradykinin)
- **DRUG:** L-NMMA + bradykinin
- **DRUG:** Isosorbide + L-NMMA + bradykinin
- **DRUG:** Sildenafil + L-NMMA + bradykinin

## Key facts

- **NCT ID:** NCT00685945
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-02-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00685945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00685945, "Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00685945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*